Dupilumab Treatment For Up To 3 Years Demonstrates Sustained Efficacy And Favorable Safety In Adult Patients With Moderate-To-Severe Atopic Dermatitis: Results From Liberty Ad Adult Ole
AUSTRALASIAN JOURNAL OF DERMATOLOGY（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要